UK / Ireland
WCAS takes Abzena private for £34.4m
Biotechnology and pharmaceutical company has previously received backing from a number of VCs
Catapult, Mercia in funding round for Rinicare
NPIF - Mercia Equity Finance is part of the Northern Powerhouse Investment Fund
European secondaries up 50% year-on-year – report
Western Europe deals saw the largest increase in H1 compared with other geographies, says Setter
Inverleith invests in Braham and Murray Good Hemp
GP plans on developing the company by drawing on its experience to reach new customers
Rede hires Amala's Simpson
Rede's seventh hire this year, most recently following the appointments of Joseph and Camacho
H2 buys Healthcare 21
GP plans to merge the two companies and create a combined group with operations across Europe
VC firms invest £2.4m in BioBeats
IQ Capital, Oxford Sciences Innovation and White Cloud Capital lead the round
BGF exits first ever investment as Bain backs Benefex
Benefex was the first investment made by BGF in 2011, with £5.5m invested overall
Bain to acquire Esure in £1.2bn take-private
Board of the UK insurance company has approved an offer of 280 pence apiece from the GP
VC-backed Orchard Therapeutics raises $150m series-C
UK-based biotechnology company is registering and launching three treatments for rare disorders
Connect leads $3m round for OurPath
Connected healthcare programme is designed to help type 2 diabetese patients reverse the disease
Round Hill in £3.3m seed round for SenSat
Funding will be used to develop SenSat's technology, including its 3D computer vision workflows
Mosaic leads $4.6m series-A for Lyvly
Greg Marsh, who co-founded hospitality startup Onefinestay, also took part in the investment
Bridgepoint sells minority stake to Dyal Capital
Mid-market GP will expand its range of investment approaches and expand internationally
Felicis closes sixth fund on $270m
Felicis has a global investment mandate and has previously invested in 40 countries
Capvest's Valeo acquires Blackstone-backed Tangerine
Reported deal for the confectionery firm comes eight months after the acquirer made a €100m bolt-on
Nystrs considering further European fund commitments
US pension fund has increased the number of active partnerships in its private equity portfolio
Andera and LSP lead $84m series-B for Artios
Biotech firm will undertake clinical proof-of-concept trials for its DNA polymerase theta programme
Felix leads $4m funding round for Unmade
Customisable fashion software company has appointed a new CTO and will look to expand internationally
BC Partners acquires VetPartners from August and Ares
Deal reportedly values the UK-based veterinary group at £700m, with BC investing from its 10th fund
Strong exit environment helps drive Pantheon's returns
Sales to corporate buyers were the most significant source of exits, PIP says in its results
BGF on track for busiest ever year
With five months to go, the UK investor is already just a few deals shy of its record deployment year
Fee structures: adventures in LP flexibility
As private equity continues to outperform other asset classes, some GPs are exploring new fee structures, with mixed results
BGF and NVM sell Wear Inns to Aprirose
Deal comes 12 years after NVM's initial investment in the pub chain and six years after BGF's